JPH10511001A - ファージ提示ベクターの製造法 - Google Patents

ファージ提示ベクターの製造法

Info

Publication number
JPH10511001A
JPH10511001A JP9510704A JP51070497A JPH10511001A JP H10511001 A JPH10511001 A JP H10511001A JP 9510704 A JP9510704 A JP 9510704A JP 51070497 A JP51070497 A JP 51070497A JP H10511001 A JPH10511001 A JP H10511001A
Authority
JP
Japan
Prior art keywords
sequence
vector
recombination
site
recombination site
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP9510704A
Other languages
English (en)
Japanese (ja)
Inventor
バンコブ，トニー
ザーラ，デイヴィッド
ジョン ホーキンス，ニコラス
リン ワード，ロビン
Original Assignee
シーアールシー フォー バイオファーマシューティカル リサーチ ピーティーワイ．リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by シーアールシー フォー バイオファーマシューティカル リサーチ ピーティーワイ．リミテッド filed Critical シーアールシー フォー バイオファーマシューティカル リサーチ ピーティーワイ．リミテッド
Publication of JPH10511001A publication Critical patent/JPH10511001A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/02—Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP9510704A 1995-09-05 1996-09-05 ファージ提示ベクターの製造法 Pending JPH10511001A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPN5239A AUPN523995A0 (en) 1995-09-05 1995-09-05 Method for producing phage display vectors
AU5239 1995-09-05
PCT/AU1996/000555 WO1997009436A1 (fr) 1995-09-05 1996-09-05 Procede de production de phages vecteurs de presentation

Publications (1)

Publication Number Publication Date
JPH10511001A true JPH10511001A (ja) 1998-10-27

Family

ID=3789568

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9510704A Pending JPH10511001A (ja) 1995-09-05 1996-09-05 ファージ提示ベクターの製造法

Country Status (5)

Country Link
EP (1) EP0850309A1 (fr)
JP (1) JPH10511001A (fr)
AU (1) AUPN523995A0 (fr)
CA (1) CA2231045A1 (fr)
WO (1) WO1997009436A1 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6143557A (en) * 1995-06-07 2000-11-07 Life Technologies, Inc. Recombination cloning using engineered recombination sites
US6720140B1 (en) 1995-06-07 2004-04-13 Invitrogen Corporation Recombinational cloning using engineered recombination sites
DE69623057T2 (de) 1995-06-07 2003-03-27 Invitrogen Corp., Carlsbad Rekombinatorische klonierung in vitro unter verwendung genmanipulierter rekombinationsorte
US6051409A (en) 1995-09-25 2000-04-18 Novartis Finance Corporation Method for achieving integration of exogenous DNA delivered by non-biological means to plant cells
US5851808A (en) 1997-02-28 1998-12-22 Baylor College Of Medicine Rapid subcloning using site-specific recombination
ATE341621T1 (de) * 1997-10-24 2006-10-15 Invitrogen Corp Rekombinatorisches klonieren unter verwendung von nukleinsaüren mit rekombinationsstellen
US7102055B1 (en) 1997-11-18 2006-09-05 Pioneer Hi-Bred International, Inc. Compositions and methods for the targeted insertion of a nucleotide sequence of interest into the genome of a plant
NZ504300A (en) * 1997-11-18 2002-06-28 Pioneer Hi Bred Int A method for directional stable transformation of eukaryotic cells using non-identical recombination sites
DE69841438D1 (de) 1997-11-18 2010-02-25 Pioneer Hi Bred Int Mobilisierung eines viralen genoms aus t-dna durch ortsspezifische rekombinationssysteme
ATE317440T1 (de) 1997-11-18 2006-02-15 Pioneer Hi Bred Int Neuartige methode zur integration von fremd-dna ins eukaryotische genom
WO2000006717A2 (fr) 1998-07-27 2000-02-10 Genentech, Inc. Efficacite de transformation amelioree de l'expression a la surface des phages par modification d'une proteine de coque
NZ525134A (en) 1999-03-02 2004-09-24 Invitrogen Corp Compositions and methods for use in recombinational cloning of nucleic acids
US7198924B2 (en) 2000-12-11 2007-04-03 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
US7560622B2 (en) 2000-10-06 2009-07-14 Pioneer Hi-Bred International, Inc. Methods and compositions relating to the generation of partially transgenic organisms
US20030235814A1 (en) * 2002-06-19 2003-12-25 Los Alamos National Laboratory Compositions and methods for selecting open reading frames
EP1697534B1 (fr) 2003-12-01 2010-06-02 Life Technologies Corporation Molecule d'acide nucleique contenant des sites de recombinaison et leurs procedes d'utilisation
ATE523603T1 (de) 2008-11-21 2011-09-15 Chimera Biotec Gmbh Konjugatkomplexe zum analytnachweis
US9712606B2 (en) * 2014-05-21 2017-07-18 Nasdaq Technology Ab Efficient and reliable host distribution of totally ordered global state
BR112019009316A2 (pt) 2016-12-26 2019-08-06 Japan Chem Res anticorpo antirreceptor de transferrina humana, proteína de fusão, fragmento de dna, vetor de expressão, célula de mamífero, complexo de composto farmacologicamente ativo e de anticorpo antirreceptor de transferrina humana, usos do anticorpo antirreceptor de transferrina humana e da proteína de fusão, e, métodos para tratamento de um distúrbio do sistema nervoso central e de uma doença do sistema nervoso central que acompanha a doença de pompe, a síndrome de hurler ou a síndrome de hurler-scheie.
AU2017385274B2 (en) 2016-12-26 2024-02-22 Jcr Pharmaceuticals Co., Ltd. Fusion protein including BDNF
EP3750921A4 (fr) 2018-02-05 2021-11-10 JCR Pharmaceuticals Co., Ltd. Procédé d'administration d'un médicament à un muscle
MX2024005968A (es) 2021-11-19 2024-08-06 Jcr Pharmaceuticals Co Ltd Peptido que tiene afinidad por el receptor de transferrina humano.

Also Published As

Publication number Publication date
AUPN523995A0 (en) 1995-09-28
CA2231045A1 (fr) 1997-03-13
WO1997009436A1 (fr) 1997-03-13
EP0850309A1 (fr) 1998-07-01

Similar Documents

Publication Publication Date Title
JPH10511001A (ja) ファージ提示ベクターの製造法
JP3485560B2 (ja) ランダムフラグメント化および再組立によるｄｎａ変異誘発
US7485426B2 (en) Method and kits for preparing multicomponent nucleic acid constructs
JP4580106B2 (ja) 核酸の組換えクローニングにおける使用のための組成物および方法
US6495318B2 (en) Method and kits for preparing multicomponent nucleic acid constructs
JP4015193B2 (ja) 反復的選択および組換えにより所望の特徴を有するポリヌクレオチドを作製する方法
AU766253B2 (en) Modulation of polypeptide display on modified filamentous phage
US6599697B1 (en) Process for preparing a multicombinatorial library of vectors for expressing antibody genes
EP1131421B1 (fr) Methodes de preparation de banques d'acides nucleiques et de polypeptides et utilisations de telles banques
AU2010217551B2 (en) Signal sequence-independent pIX phage display
KR100491810B1 (ko) 무작위단편화및재조립에의한dna돌연변이유발방법
US8728983B2 (en) Phage display vector
US6440700B1 (en) Method of combinatorial protein synthesis based on ribosomal frameshifting
WO2004090139A1 (fr) Procede pour la realisation de banques de sequences genetiques randomisees dans des cellules
Dottavio Phagemid-displayed peptide libraries
WO2003097796A2 (fr) Presentation de fabs a la surface d'un bacteriophage t7
CA2282179A1 (fr) Presentoir de librairie a phage ameliore